RE:RE:RE:seeking Alpha Yes this looks encouraging but the report acknowledges that dates listed are projections. Let's hope it happens. A december BLA approval is possible provided the plant inspection purportedly undertaken last week is favourable. Perhaps there will be a PR on the outcome of the inspection this week or next??
2017 Fall Pipeline Update
Oklahoma Health Care Authority
November 2017
Introduction
The following report is a pipeline review compiled by the University of Oklahoma College of
Pharmacy. Information in this report is focused on medications not yet approved by the U.S.
Food and Drug Administration (FDA). The pipeline report is not an all-inclusive list, and
medications expected to be highly utilized or have a particular impact in the SoonerCare
population have been included for review. Pipeline data is collected from a variety of sources
and is subject to change; dates listed are projections and all data presented are for
informational purposes only. Costs listed in the following report do not reflect rebated prices or
net costs. For Ryplazim the anticipated FDA response date is 12/2017.